Modified biovectors for the tuneable activation of anti-platelet carbon monoxide release

Prieto, Lucas; Rossier, Jeremie; Derszniak, Katarzyna; Dybas, Jakub; Oetterli, René M.; Kottelat, Emmanuel; Chlopicki, Stefan; Zelder, Felix; Zobi, Fabio

doi:10.1039/C7CC03642F

Back

Journal article

+ 1 other files

Modified biovectors for the tuneable activation of anti-platelet carbon monoxide release

Prieto, Lucas University of Zurich, Department of Chemistry, Switzerland
Rossier, Jeremie Department of Chemistry, University of Fribourg, Switzerland
Derszniak, Katarzyna Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland
Dybas, Jakub Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland
Oetterli, René M. University of Zurich, Department of Chemistry, Switzerland
Kottelat, Emmanuel Department of Chemistry, University of Fribourg, Switzerland
Chlopicki, Stefan Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland - Chair of Pharmacology, Jagiellonian University Medical College, Krakow, Poland
Zelder, Felix University of Zurich, Department of Chemistry, Switzerland
Zobi, Fabio Department of Chemistry, University of Fribourg, Switzerland

22.06.2017

Published in:

Chemical Communications. - 2017, vol. 53, no. 51, p. 6840–6843

English This communication describes the anti-platelet effects of a new class of cis-rhenium(II)- dicarbonyl-vitamin B12 complexes (B12-ReCORMs) with tuneable CO releasing properties.

Faculty

Faculté des sciences et de médecine

Department

Département de Chimie

Language